Approximately 5–10% of BC cases are associated with a strong hereditary component and 15–25% of familial aggregations are due to mutations in the BRCA1 (MIM# 113705) or BRCA2 (MIM# 600185) genes [4,5,6,7]. Here, BRCA2 is linked to breast cancer.